Loading clinical trials...
Loading clinical trials...
An Open-Label Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Iduronate-2-Sulfatase Enzyme Replacement Therapy
Conditions
Interventions
Idursulfase
Locations
52
United States
St. Joseph's Hospital
Phoenix, Arizona, United States
Pediatric Clinical Research Center, Children's Hospital Oakland
Oakland, California, United States
The Children's Hospital
Denver, Colorado, United States
Harbin Clinic
Rome, Georgia, United States
Mid-Illinois Hematology and Oncology Associates
Normal, Illinois, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Start Date
September 13, 2004
Primary Completion Date
January 31, 2008
Completion Date
January 31, 2008
Last Updated
June 10, 2021
NCT05422482
NCT05795361
NCT01506141
NCT02412787
NCT05058391
NCT03920540
Lead Sponsor
Shire
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions